Drug for the treatment of the neoplastic disease
CA 1203167 A · Owner: Intreprinderea De Medicamente Biofarm · Inventors: Danila, Mihai
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Medicine for the Treatment of Neoplazic Disease ABSTRACT OF THE DISCLOSURE:, Medicine for the treatment of the neoplazic disease presented as a set of three drug types in which hydroquinone and metole with or without double aluminium and potassium sulphate are mixed in operculated capsules the uranyl, nitrate being dissolved in a Coridalis marchalima infusion which contains methylene blue, and in order to intensify its effect on the muscular tissue, an alcoholic vegetal tincture obtained from Potentilla reptans, Helleborus niger and Medicago sativa is used as a treatment aid.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 15, 1986. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 15, 2003.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.